Nelson Lourenco - Publications

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.

Journal: The oncologist

Published: February 13, 2025

Brief Report: Pancreatic Cancer in People With HIV: A Case-Control Study.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: July 01, 2024

Metastatic perirectal PEComa treated by checkpoint inhibitor immunotherapy and multimodal treatment: case report and review of the literature.

Journal: Therapeutic advances in medical oncology

Published: May 01, 2024

Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.

Journal: Scandinavian journal of gastroenterology

Published: February 14, 2024

Cryptococcal meningitis and cerebral vasculitis in a patient with primary intestinal lymphangiectasia: a case report.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: May 17, 2023

Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 07, 2022

Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study.

Journal: Annals of translational medicine

Published: February 08, 2021

Recurrence of Immune-Mediated Colitis Upon Immune Checkpoint Inhibitor Resumption: Does Time Matter?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 10, 2019

Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 02, 2019

Severe gastrointestinal toxicity of MEK inhibitors.

Journal: Melanoma research

Published: May 17, 2019

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study.

Journal: Therapeutic advances in gastroenterology

Published: May 03, 2019

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.

Journal: Clinics and research in hepatology and gastroenterology

Published: February 04, 2019